CTOs on the Move

LifeGift

www.lifegift.org

 
LifeGift offers hope to the thousands of people in Texas and beyond who need lifesaving organ transplants, and to countless others who need lifesaving tissue transplants. As the designated organ procurement organization (OPO) for North, Southeast and West Texas, we partner with more than 200 hospitals across 109 counties. Established in 1987 as Gulf Coast Independent Organ Procurement Organization, LifeGift is approved by the Centers for Medicare and Medicaid Services (CMS) and accredited by the Association of Organ Procurement Organizations (AOPO) and the American Association of Tissue Banks (AATB).
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.lifegift.org
  • 2510 Westridge Street
    Houston, TX USA 77054
  • Phone: 713.523.4438

Executives

Name Title Contact Details

Similar Companies

American Imaging Management

American Imaging Management, Inc. is a Deerfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Radiancy, Inc.

Radiancy, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Orangeburg, NY. To find more information about Radiancy, Inc., please visit www.radiancy.com

ODA Primary Health Care Center

ODA Primary Health Care Center is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alta Bates Medical Group

Alta Bates Medical Group is a Emeryville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bioatla

BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.